Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173886 (US9688645, 1-1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173906 (US9688645, 3-1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.70 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173904 (US9688645, 2-1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.80 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173918 (US9688645, 5-2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173923 (US9688645, 6-3) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173908 (US9688645, 4-1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173903 (US9688645, 1-9) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173922 (US9688645, 6-2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173926 (US9688645, 7-1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173929 (US9688645, 8-1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173902 (US9688645, 1-8) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 29 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173920 (US9688645, 5-3) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 32 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173930 (US9688645, 8-2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 33 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173928 (US9688645, 7-4) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173900 (US9688645, 1-7) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 49 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173921 (US9688645, 6-1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 52 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173932 (US9688645, 6-6) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173924 (US9688645, 6-4) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173931 (US9688645, 8-3) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 59 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173897 (US9688645, 1-4) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 71 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173898 (US9688645, 1-5) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 105 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173894 (US9688645, 1-3) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 269 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173911 (US9688645, 5-1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 649 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173899 (US9688645, 1-6) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 811 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B2 (Homo sapiens (Human)) | BDBM173893 (US9688645, 1-2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.04E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
SANOFI US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ... | US Patent US9688645 (2017) BindingDB Entry DOI: 10.7270/Q2PV6HJ3 | |||||||||||
More data for this Ligand-Target Pair |